Fiera Capital (Canada)
PTLA

Fiera Capital (Canada)’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Fiera Capital (Canada)’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,703,447
Closed -$12.1M – 690
2020
Q1 		$12.1M Sell
1,703,447
-49,479
-3% -$617K 0.05% 178
2019
Q4 		$41.9M Sell
1,752,926
-126,926
-7% -$3.5M 0.14% 108
2019
Q3 		$50.4M Buy
1,879,852
+386,598
+26% +$10.9M 0.19% 82
2019
Q2 		$40.5M Sell
1,493,254
-51,116
-3% -$1.6M 0.15% 112
2019
Q1 		$53.6M Buy
+1,544,370
New +$44.6M 0.21% 80
2018
Q4 		– Sell
-27,784
Closed -$740K – 763
2018
Q3 		$740K Sell
27,784
-17,535
-39% -$573K ﹤0.01% 514
2018
Q2 		$1.71M Sell
45,319
-4,067
-8% -$156K 0.01% 426
2018
Q1 		$1.61M Sell
49,386
-5,460
-10% -$240K 0.01% 418
2017
Q4 		$2.67M Sell
54,846
-11,689
-18% -$591K 0.01% 355
2017
Q3 		$3.6M Buy
+66,535
New +$3.91M 0.02% 329

Other funds holding PTLA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
WIC
Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
VI
Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return

Fiera Capital (Canada)'s PTLA Position: Q2 2020 in Review

Fiera Capital (Canada) sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 1,703,447 shares — an estimated $12.1M sold.

Fiera Capital (Canada) first reported a position in PTLA in Q3 2017 and held it in 10 quarters. The position peaked at $53.6M in Q1 2019. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

  • Fiera Capital (Canada) reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Fiera Capital (Canada) sold 1,703,447 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $12.1M.
  • Fiera Capital (Canada) first reported a position in Portola Pharmaceuticals, Inc. in Q3 2017 and held it in 10 quarters.
  • Fiera Capital (Canada)'s Portola Pharmaceuticals, Inc. position peaked at $53.6M in Q1 2019.
  • 162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Fiera Capital (Canada)'s 13F filing for Q2 2020, filed 7 Aug 2020.